Clover Health Investments Corp.

Last updated September 27, 2026

Organization details

Legal name
Clover Health Investments Corp.
Former names
Social Capital Hedosophia Holdings Corp. III
Ownership
Public
Status
Active
Sector (GICS)
Financials
SIC code
6324 — Hospital & Medical Service Plans
Jurisdiction of incorporation
Delaware
Headquarters city
Jersey City
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CLOV
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001801170
EIN
98-1515192

Board of directors

Chief executives

Andrew Toy · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 3 other boards.

Network of Clover Health Investments Corp.'s board connections American Public Education Inc. American Public Educat... Expedia Group Inc. Expedia Group Inc. People Incorporated People Incorporated Chelsea Clinton Chelsea Clinton William G. Robinson Jr. William G. Robinson... Clover Health Investments...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$8,821,159
42 sales by 8 insiders
Date Insider Transaction Shares Price Value
Nov 16, 2026 THORNTON JOSEPH CLAY Officer (Chief Financial Officer) Open-market sale −22,099 $4.97 $109,832
Nov 4, 2026 THORNTON JOSEPH CLAY Officer (Chief Financial Officer) Grant or award +328,947 — —
Nov 4, 2026 OLDAKOWSKI JOSEPH FRANK Officer (Chief Accounting Officer) Grant or award +186,403 — —
Oct 20, 2026 Soares Karen Officer (Chief Legal Officer) Open-market sale −19,275 $4.66 $89,822
Oct 19, 2026 Reynoso Jamie L. Officer (CEO, Medicare Advantage) Open-market sale −4,066 $4.41 $17,931
Oct 15, 2026 Reynoso Jamie L. Officer (CEO, Medicare Advantage) Open-market sale −18,273 $4.68 $85,518
Oct 15, 2026 Wai Conrad Officer (CEO, Counterpart Health) Open-market sale −23,627 $4.68 $110,574
Oct 15, 2026 THORNTON JOSEPH CLAY Officer (Interim CFO) Open-market sale −4,591 $4.68 $21,486
Oct 15, 2026 Soares Karen Officer (Chief Legal Officer) Open-market sale −14,673 $4.68 $68,670
Oct 15, 2026 Andrew Toy Director, Officer (Chief Executive Officer) Open-market sale −62,176 $4.68 $290,984
Oct 7, 2026 Reynoso Jamie L. Officer (CEO, Medicare Advantage) Open-market sale −2,006 $4.63 $9,288
Oct 5, 2026 Reynoso Jamie L. Officer (CEO, Medicare Advantage) Open-market sale −8,750 $4.42 $38,675
Oct 1, 2026 Andrew Toy Director, Officer (Chief Executive Officer) Open-market sale −318,806 $4.19 $1,335,797
Sep 30, 2026 Robert G. Torricelli Director Grant or award +12,481 — —
Sep 30, 2026 Brian James Miller Director Grant or award +12,481 — —

Organizations in the same sector, closest in location and size first.

Questions about Clover Health Investments Corp.

Who is the CEO of Clover Health Investments Corp.?

Andrew Toy is Clover Health Investments Corp.'s Chief Executive Officer.

How many directors are on Clover Health Investments Corp.'s board?

Clover Health Investments Corp.'s board has 11 directors: Andrew Toy, Anna U. Loengard, Brian James Miller, Carladenise Armbrister Edwards, Chelsea Clinton, Demetrios L. Kouzoukas, Lee Shapiro, Robert G. Torricelli, Thomas L. Tran, Vivek Garipalli and 1 other.

Are Clover Health Investments Corp. insiders buying or selling shares?

Over the last 12 months, Clover Health Investments Corp. insiders made no open-market purchases and sold $8.8 million of shares in 42 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="clover-health-investments-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.